Growth of Platelet and Plasma Market Forecast to 2024 in a Newly Released Report Profiling American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China

Platelet and plasma market has received a tremendously positive impetus as a slew of research and development activities on human blood has deepened and brought to the forefront some of its unparalleled healing properties. Several innovative plasma-fractionation procedures have become popular in the healthcare landscape that have used human blood to produce plasma-derived therapies. The list of chronic and life-threatening disorders that can be cured by plasma derived therapies has lengthened and as a result platelet and plasma market has been projected to register a commendable growth rate in the forthcoming years.

MarketStudyReport.com Adds New Platelet and Plasma Market 2018 – 2024 research report providing information and data By Component, By Application, By Distribution Channel, By Region, Industry Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast spreading across 120 Pages with table and figures in it.

Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1206946/

Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in 2017. Many developed countries provide a mixed system of compensated as well non-compensated blood donation. Moreover, various government initiatives to encourage blood donation among people will further accelerate the market growth during the forthcoming years.

Thrombocytopenia segment will grow at a robust CAGR of around 2.9% over the foreseeable period attributable to the growing number of thrombocytopenia cases worldwide. Thrombocytopenia is characterized by reduced platelet count owing to number of factors such as chemotherapy drugs, heavy alcohol consumption and leukemia. According to the Journal of Hepatology, thrombocytopenia is commonly found in around 76% patients suffering from chronic liver diseases. Rising prevalence of rare infectious diseases coupled with growing elderly population base will fuel the demand for platelets and plasma over the forecast period.

Hospitals segment dominated the market in 2017 with a revenue share of around 62.5% and is estimated to show remarkable growth in the coming years. Rising number of hospitalizations owing to prevalence of chronic diseases such as hepatitis C, hemophilia and other rare diseases will drive the platelets and plasma market growth during the analysis period. Availability of advanced healthcare facilities, growing elderly patient base as well as reimbursement policies for hospital treatments will upsurge the size of platelets and plasma market during the analysis timeframe.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1206946/

U.S. platelets and plasma market accounted for the highest revenue of USD 2 billion in 2017 owing to the rising incidences of chronic diseases coupled with increasing geriatric population base will augment the market growth. For instance, plasma is used in the treatment of neurological disorders such as multiple sclerosis, inflammatory dysimmune neuropathies and myasthenia gravis. High adoption of technological advancements as well as availability of advanced healthcare facilities will drive the market growth. Moreover, increased smoking, lifestyle changes and other environmental factors will further boost the demand for platelets and plasma during the forthcoming years.

Some of the notable industry players of global platelets and plasma market are America?s Blood Centers, American Red Cross, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Spanish Red Cross, Saudi Red Crescent Authority and South Africa Red Cross Society. Industry players are primarily focusing on developing novel technologies to diversify the product applications for treatment of various diseases. They are also emphasizing on mergers, partnerships and collaborations to encourage blood donation and use of blood components in disease treatments.

Table of Content:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Platelet And Plasma Industry Insights
Chapter 4. Platelet And Plasma Market, By Component
Chapter 5. Platelet And Plasma Market, By Application
Chapter 6. Platelet And Plasma Market, By Distribution Channel
Chapter 7. Platelet and Plasma Market, By Region
Chapter 8. Company Profiles

More Details on this Report At: https://www.marketstudyreport.com/reports/platelet-and-plasma-market

Outer scope of this report Immunoglobin, albumin and coagulation factor concentrates have mostly driven the expansion of the platelet and plasma market. Immunoglobin is used to help patients suffering from various immunodeficiency disorders and to fight viral and bacterial infections as well as a range of neurological diseases including post-polio syndrome, multiple sclerosis and neuropathic pain. Recent research has indicated that intravenous immunoglobin can prove extremely valuable for the treatment of Alzheimer’s. Albumin is used to treat patients with cardiopulmonary disease and liver conditions besides being useful for treatment of stroke, cirrhosis, malaria and sepsis. Coagulation factor concentrates save lives by preventing bleeding in patients with coagulation-related disorders such as hemophilia, von Willebrand disease and others. Statistics provided by American Red Cross indicate that 10,000 units of plasma and 7,000 units of platelets are in demand daily in the U.S. Added to this figure is the demand for blood components in war ravaged areas and places of high casualty, which will add a potential boost to platelet and plasma market growth over the ensuing years.

Related Report:

Global Platelet and Plasma Industry Market Analysis & Forecast 2018-2023

In the Global Platelet and Plasma Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

https://www.marketstudyreport.com/reports/global-surgical-staplers-industry-market-analysis-forecast-2018-2023

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

This release was published on openPR.